altretamine
Selected indexed studies
- Altretamine. (, 2012) [PMID:31643842]
- Altretamine. (DICP, 1991) [PMID:1905441]
- Clinical pharmacokinetics of altretamine. (Clin Pharmacokinet, 1995) [PMID:7656502]
_Worker-drafted node — pending editorial review._
Connections
altretamine is a side effect of
Sources
- Altretamine. (2012) pubmed
- Altretamine. (1991) pubmed
- Clinical pharmacokinetics of altretamine. (1995) pubmed
- Altretamine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cancer chemotherapy. (1995) pubmed
- Mode of interaction of altretamine with calf thymus DNA: biophysical insights. (2023) pubmed
- Hexamethylmelamine (altretamine): early National Cancer Institute trials. (1991) pubmed
- Hexamethylmelamine (altretamine) in small cell lung cancer (SCLC). (1991) pubmed
- Anticancer altretamine recognition by bovine serum albumin and its role as inhibitor of fibril formation: Biophysical insights. (2019) pubmed
- The Combined Anti-Tumor Efficacy of Bioactive Hydroxyapatite Nanoparticles Loaded with Altretamine. (2023) pubmed
- Altretamine (hexamethylmelamine) in the treatment of platinum-resistant ovarian cancer: a phase II study. (2003) pubmed